Pharmadrug Releases Encouraging Q3 Financials and Forecasts Solid Profits in 2020

During the third quarter, ended September 30, 2019, Pharmadrug (CA:BUZZ – $0.03 & US:LMLLF – $0.03) reached revenues of $271,000 with a gross margin of $67,000, or 25%. Gross margin is expected to improve to 40% over the coming quarters. Recall that Pharmadrug has two supply agreements where it will be paying €4,00 per gram of cannabis while it is […]

Read more

Pharmadrug Stands To Benefit Significantly From Export Ruling In Israel

Pharmadrug (CA:BUZZ – $0.04 & US:LMLLF – $0.03) announced earlier this week that Israel’s Ministry of Health will soon be publishing its guidelines regarding the export law on medical cannabis that was passed in January. These guidelines will enable companies to start exporting cannabis grown in Israel to Germany and other European markets. An article posted by BH Synergy Group […]

Read more

Pharmadrug All Set For Exponential Growth in European Cannabis Market

Pharmadrug Inc. (CA:BUZZ – $0.05 & US:LMLLF – $0.02) announced a multi-year supply agreement between its 80% owned German subsidiary Pharmadrug Production GmbH and Canada House Wellness Group Inc. [CSE: CHV]. The agreement is part of the Company’s plan to aggressively pursue the medical and potentially recreational cannabis market in Germany and the rest of Europe. All cannabis will be […]

Read more

Aura Health Signals Turning Point With Name Change To Pharmadrug Inc.

Aura Health (CA:BUZZ – $0.04 & US:LMLLF – $0.02) completed its previously announced name change to Pharmadrug Inc. this week. This name better reflects the Company’s core business and models itself after its 80% owned German subsidiary, Pharmadrug Production GmbH. This is a smart move by the Company as part of a greater initiative to expand the distribution and brand […]

Read more

Aura Health Stock Price Shoots Up Thanks to Important Supply Agreement

Just a few days after our initial Research Report on Aura Health (CA:BUZZ – $0.07 & US:LMLLF – $0.05) was published, the Company surprised the markets with a multi-year supply agreement at very attractive conditions. Aura is building a vertically-integrated medical cannabis company with a focus on the European market. In order to do so, the Company established a beachhead […]

Read more

How Aura Health Is Building Tremendous Value in European Cannabis Market

Aura Health (CA:BUZZ – $0.06 & US:LMLLF – $0.05) is building a leading vertically-integrated medical cannabis company with a focus on the European and Israeli markets. Reasons to own Aura Health stock: 1. A cannabis gateway to Europe: by 2028 the European medical cannabis market is estimated to be $123 billion, making it the largest cannabis market on the planet. […]

Read more

Europe-Focused Cannabis Player Ready for Takeoff

We’re excited about the interview that we conducted with Mr. Daniel Cohen, the Chief Executive Officer of Aura Health Inc. (CA:BUZZ – $0.07 & US:LMLLF – $0.06). The Company is focused on building an international network of vertically-integrated cannabis assets with a clear focus on Europe. Mr. Cohen first discusses Pharmadrug, a German importer and distributor of medical cannabis, of […]

Read more